1-Methyltryptophan
Chemical compound
From Wikipedia, the free encyclopedia
1-Methyltryptophan is a chemical compound that is an inhibitor of the tryptophan catabolic enzyme indoleamine 2,3-dioxygenase (IDO or INDO EC 1.13.11.52).[1] It is a chiral compound that can exist as both D- and L-enantiomers.
| Names | |
|---|---|
| IUPAC name
1-Methyltryptophan | |
| Systematic IUPAC name
2-Amino-3-(1-methyl-1H-indol-3-yl)propanoic acid | |
| Other names
1-Methyl-DL-tryptophan; DL-1-Methyltryptophan; ARBRIN; Indoximod | |
| Identifiers | |
| |
3D model (JSmol) |
|
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.043.765 |
PubChem CID |
|
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C12H14N2O2 | |
| Molar mass | 218.256 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
The L-isomer (L-1MT) inhibits IDO weakly but also serves as an enzyme substrate.
The D-isomer (D-1MT) does not inhibit IDO at all, but it can inhibit the IDO-related enzyme IDO2[2] and restore mTOR signaling in cells starved of tryptophan due to IDO activity.[3] D-1MT is also known as indoximod and it was in clinical trials for cancer treatment, such as for advanced melanoma, in 2017.[4][needs update]
A U.S. patent covering salt and prodrug formulations of indoximod was issued to NewLink Genetics on August 15, 2017, providing exclusivity until at least 2036.[5][6]
